Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6665-6670

  Mear, John P ^a   Schreiber, Kathy L ^a   Münz, Christian ^b   Zhu, Xiaoming ^a   Stevanović, Stefan ^b   Rammensee, Hans Georg ^b   Rowland Jones, Sarah L ^c   Colbert, Robert A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; CYTOSOL; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; SPONDYLOARTHROPATHY;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; ARTHRITIS; CYTOSOL; DISEASE SUSCEPTIBILITY; HLA-B27 ANTIGEN; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN FOLDING; SPONDYLITIS;

EID: 0032742012     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Khan, A. 1998. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In The Spondyloarthritides. A. Calin and J. D. Taurog, eds. Oxford University Press, Oxford, p. 17.
2. Rubin, L. A., C. I. Amos, J. A. Wade, J. R. Martin, S. J. Bale, A. H. Little, D. D. Gladman, G. E. Bonney, J. D. Rubenstein, and K. A. Siminovitch. 1994. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum. 37:1212.
3. 2-m: an animal model of HLA-B27-associated human disorders. Cell 63:1099.
4. 2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182:1153.
5. Weinreich, S., F. Eulderink, J. Capkova, M. Pla, K. Gaede, J. Heesemann, L. van Alphen, C. Zurcher, B. Hoebe-Hewryk, F. Kievits, et al. 1995. HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum. Immunol. 42:103.
6. Benjamin, R. J., and P. Parham. 1990. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11:137.
7. Hermann, E., D. T. Y. Yu, K.-H. Meyer zum Buschenfelde, and B. Fleischer. 1993. HLA-B27-restricted CD8 T cells from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342:646.
8. Burmester, G. R., A. Daser, T. Kamradt, A. Krause, N. A. Mitchison, J. Sieper, and N. Wolf. 1995. Immunology of reactive arthritides. Annu. Rev. Immunol. 13:229.
9. Marker-Hermann, E., K.-H. Meyer zum Buschenfelde, and G. Wildner. 1997. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Arthritis Rheum 40:2047.
10. Breban, M., J. L. Fernandez-Sueiro, J. A. Richardson, R. R. Hadavand, S. D. Maika, R. E. Hammer, and J. D. Taurog. 1996. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156:794.
11. Parham, P. 1996. Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol. Rev. 154: 137.
12. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
13. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
14. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H.-G. Rammensee. 1994. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
15. Boisgerault, F., V. Tieng, M.-C. Stolzenberg, N. Dulphy, I. Khalil, R. Tamouza, D. Charron, and A. Toubert. 1996. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. J. Clin. Invest. 989:2764.
16. Griffin, T. A., J. Yuan, T. Friede, S. Stevanovic, K. Ariyoshi, S. L. Rowland-Jones, H.-G. Rammensee, and R. A. Colbert. 1997. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. J. Immunol. 159:4887.